ASH 2021 packed with practice-changing hematologic cancer data

Sigurdur Yngvi Kristinsson professor of hematology at the University of Iceland Faculty of Medicine, specialist at Landspitali University Hospital and iStopMM´s principal investigator has been

In May 2021 iStopMM reached an important milestone, with the publication of the first results of the screening study in its first article, “Iceland screens,

Researchers at iStopMM have for the first time described the prevalence of smoldering multiple myeloma and the findings indicate that it is present in 0.5%